# Citations for Research Query

**Query:** # Disease Pathophysiology Research Template

## Target Disease
- **Disease Name:** Lymphoma
- **MONDO ID:**  (if available)
- **Category:** Cancer

## Research Objectives

Please provide a comprehensive research report on the pathophysiology of **Lymphoma**.
Focus on the molecular and cellular mechanisms underlying disease progression.

### Required Information

#### 1. Core Pathophysiology
- What are the primary pathophysiological mechanisms?
- What molecular pathways are dysregulated?
- What cellular processes are affected?

#### 2. Key Molecular Players
- **Genes/Proteins**: Which genes are causally involved or implicated?
- **Chemical Entities**: What metabolites, drugs, or small molecules are relevant?
- **Cell Types**: Which cell types are primarily affected?
- **Anatomical Locations**: Which tissues/organs are involved?

#### 3. Biological Processes (for GO annotation)
- What biological processes (GO terms) are disrupted?
- Consider: signaling pathways, metabolic processes, cellular responses, transport, etc.

#### 4. Cellular Components
- Where in the cell do key processes occur?
- Consider: organelles, membrane compartments, extracellular space, etc.

#### 5. Disease Progression
- What is the sequence of events from initial trigger to clinical manifestation?
- Are there distinct stages or phases?

#### 6. Phenotypic Manifestations
- What are the key clinical phenotypes?
- How do they relate to the underlying mechanisms?

### Citation Requirements

- Cite primary literature (PMID preferred) for all mechanistic claims
- Prioritize recent reviews and landmark papers
- Include direct quotes where possible to support key statements

### Output Format

Structure your response as a narrative that could be used to populate a disease knowledge base entry with:
- Pathophysiology description
- Gene/protein annotations with ontology terms (HGNC, GO)
- Phenotype associations (HP terms)
- Cell type involvement (CL terms)
- Anatomical locations (UBERON terms)
- Chemical entities (CHEBI terms)
- Evidence items with PMIDs

**Provider:** perplexity
**Generated:** 2026-02-01T09:11:24.897481

1. https://pmc.ncbi.nlm.nih.gov/articles/PMC10994807/
2. https://ashpublications.org/blood/article/133/15/1664/273305/Genetic-drivers-of-oncogenic-pathways-in-molecular
3. https://pmc.ncbi.nlm.nih.gov/articles/PMC5043587/
4. https://ascopubs.org/doi/10.1200/JCO.2010.32.8401
5. https://pmc.ncbi.nlm.nih.gov/articles/PMC5214175/
6. https://www.roswellpark.org/sites/default/files/hernandez_4-25-17_paper_4_nrc1589.pdf
7. https://www.canceraustralia.gov.au/cancer-types/lymphoma/types-lymphoma
8. https://www.rarediseaseadvisor.com/hcp-resource/diffuse-large-b-cell-lymphoma-pathophysiology/
9. https://pmc.ncbi.nlm.nih.gov/articles/PMC7927991/
10. https://www.ncbi.nlm.nih.gov/books/NBK559328/
11. https://www.ncbi.nlm.nih.gov/books/NBK557796/
12. https://haematologica.org/article/view/7765
13. https://pubmed.ncbi.nlm.nih.gov/24679006/
14. https://www.jci.org/articles/view/61245/figure/2
15. https://pmc.ncbi.nlm.nih.gov/articles/PMC4957136/
16. https://haematologica.org/article/view/haematol.2021.279631
17. https://pmc.ncbi.nlm.nih.gov/articles/PMC9495867/
18. https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2023.1199108/full
19. https://pmc.ncbi.nlm.nih.gov/articles/PMC6948841/
20. https://pmc.ncbi.nlm.nih.gov/articles/PMC2989778/
21. https://pmc.ncbi.nlm.nih.gov/articles/PMC4993814/
22. https://ashpublications.org/blood/article/120/14/2864/30499/IgH-partner-breakpoint-sequences-provide-evidence
23. https://ashpublications.org/blood/article/110/6/2121/24149/Nuclear-CD40-interacts-with-c-Rel-and-enhances
24. https://www.bloodresearch.or.kr/journal/view.html?doi=10.5045%2Fbr.2022.2022037
25. https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2018.00533/full
26. https://pubmed.ncbi.nlm.nih.gov/24333723/
27. https://www.oncotarget.com/article/25072/text/
28. https://pmc.ncbi.nlm.nih.gov/articles/PMC9597512/
29. https://pmc.ncbi.nlm.nih.gov/articles/PMC10716070/
30. https://pmc.ncbi.nlm.nih.gov/articles/PMC10648005/
31. https://pmc.ncbi.nlm.nih.gov/articles/PMC7341547/
32. https://journals.plos.org/plospathogens/article?id=10.1371%2Fjournal.ppat.1011954
33. https://pubmed.ncbi.nlm.nih.gov/15618006/
34. https://haematologica.org/article/view/4959
35. https://pmc.ncbi.nlm.nih.gov/articles/PMC10538126/
36. https://www.ncbi.nlm.nih.gov/books/NBK542333/
37. https://www.pnas.org/doi/10.1073/pnas.82.9.2900
38. https://pmc.ncbi.nlm.nih.gov/articles/PMC1769756/
39. https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2018.00556/full
40. https://pmc.ncbi.nlm.nih.gov/articles/PMC3904095/
41. https://pmc.ncbi.nlm.nih.gov/articles/PMC7461610/
42. https://aacrjournals.org/cancerres/article/82/17/2955/708282/Metabolic-Reprogramming-in-Hematologic
43. https://www.mayoclinic.org/diseases-conditions/lymphoma/symptoms-causes/syc-20352638
44. https://ashpublications.org/blood/article/112/11/5279/63020/Clinical-Implications-of-Immunophenotyping-in
45. https://pubmed.ncbi.nlm.nih.gov/16304397/
46. https://www.mdanderson.org/cancerwise/how-i-knew-i-had-lymphoma--survivors-describe-their-symptoms.h00-159700701.html
47. https://pubmed.ncbi.nlm.nih.gov/9830628/
48. https://www.hmpgloballearningnetwork.com/site/frmc/news/indolent-aggressive-understanding-lymphoma-transformation
49. https://pmc.ncbi.nlm.nih.gov/articles/PMC10868116/
50. https://pmc.ncbi.nlm.nih.gov/articles/PMC12293259/
51. https://pmc.ncbi.nlm.nih.gov/articles/PMC4626253/
52. https://pharmacomedicale.org/medicaments/par-specialites/item/cytokines-et-anti-cytokines-les-points-essentiels
53. https://www.sfdiabete.org/files/files/JNDES/2019/1_mced95_vuagnat.pdf
54. https://www.aihemato.com/AIH/documents/Cours%20DES/DES%202022-02-25/Oncogenese-molecule-LF-Sandrine-Roulland.pdf
55. https://ajronline.org/doi/10.2214/AJR.10.7266
56. https://pmc.ncbi.nlm.nih.gov/articles/PMC9913816/
57. https://pmc.ncbi.nlm.nih.gov/articles/PMC10505605/
58. https://pmc.ncbi.nlm.nih.gov/articles/PMC12283638/
59. https://www.lymphoma.ca/lymphoma/non-hodgkin-lymphoma/classifying-nhl/